Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
9.26
-0.24 (-2.53%)
At close: Apr 28, 2026, 4:00 PM EDT
9.33
+0.07 (0.76%)
After-hours: Apr 28, 2026, 6:59 PM EDT

Climb Bio Stock Forecast

Stock Price Forecast

The 11 analysts that cover Climb Bio stock have a consensus rating of "Strong Buy" and an average price target of $16.82, which forecasts a 81.64% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $26.

Price Target: $16.82 (+81.64%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$8.00$16.82$17$26
Change-13.61%+81.64%+83.59%+180.78%

Analyst Ratings

The average analyst rating for Climb Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingNov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy233366
Buy333456
Hold000000
Sell000000
Strong Sell000000
Total56671112

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Oppenheimer
Oppenheimer
Buy
Maintains
$10$18
BuyMaintains$10$18+94.38%Apr 21, 2026
Mizuho
Mizuho
Buy
Initiates
$18
BuyInitiates$18+94.38%Apr 15, 2026
BTIG
BTIG
Strong Buy
Reiterates
$8
Strong BuyReiterates$8-13.61%Apr 8, 2026
B. Riley Securities
B. Riley Securities
Strong Buy
Initiates
$26
Strong BuyInitiates$26+180.78%Mar 24, 2026
Truist Securities
Truist Securities
Strong Buy
Initiates
$17
Strong BuyInitiates$17+83.59%Mar 18, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.10
from -0.90
EPS Next Year
-1.28
from -1.10
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
-------
Revenue Growth
-------
EPS
-4.24-1.72-1.30-1.53-0.90-1.10-1.28
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1414
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030203120322033
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030203120322033
High--
Avg--
Low--

EPS Forecast

EPS20262027202820292030203120322033
High-0.98-1.17
Avg-1.10-1.28
Low-1.18-1.48

EPS Growth

EPS Growth20262027202820292030203120322033
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.